InMed Pharmaceuticals Inc.
INM
$2.76
$0.010.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.12M | -2.58M | -1.68M | -1.94M | -1.72M |
| Total Depreciation and Amortization | 129.60K | 129.10K | 145.00K | 151.90K | 150.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 66.40K | 37.90K | 33.70K | 91.00K | 56.70K |
| Change in Net Operating Assets | 265.40K | -94.10K | -327.60K | 665.60K | -418.80K |
| Cash from Operations | -1.66M | -2.50M | -1.83M | -1.03M | -1.93M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.94M | 396.20K | 1.03M | 200.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -15.10K | -57.60K | -191.80K | -- | 0.00 |
| Cash from Financing | 2.92M | 338.50K | 838.20K | 200.00 | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.26M | -2.16M | -988.60K | -1.03M | -1.93M |